NOVEL COMPOUNDS

The present invention relates to inhibitors of the Wnt signalling pathways of general formula (I) as described and defined herein, to methods of preparing said compounds, to intermediate compounds useful for preparing said compounds, to pharmaceutical compositions and combinations comprising said co...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: SCOTT William, MÖWES Manfred, LIENAU Philip, GOLZ Stefan, BASTING Daniel, SIEGEL Franziska, BENDER Eckhard, THEDE Kai, ZORN Ludwig, PUEHLER Florian, SCHNEIDER Dirk, HÄGEBARTH Andrea, MÖNNING Ursula, GEISLER Jens, GIESE Anja, LIU Ningshu
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator SCOTT William
MÖWES Manfred
LIENAU Philip
GOLZ Stefan
BASTING Daniel
SIEGEL Franziska
BENDER Eckhard
THEDE Kai
ZORN Ludwig
PUEHLER Florian
SCHNEIDER Dirk
HÄGEBARTH Andrea
MÖNNING Ursula
GEISLER Jens
GIESE Anja
LIU Ningshu
description The present invention relates to inhibitors of the Wnt signalling pathways of general formula (I) as described and defined herein, to methods of preparing said compounds, to intermediate compounds useful for preparing said compounds, to pharmaceutical compositions and combinations comprising said compounds and to the use of said compounds for manufacturing a pharmaceutical composition for the treatment or prophylaxis of a disease, in particular of a hyper-proliferative disorder, as a sole agent or in combination with other active ingredients.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US2017107212A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US2017107212A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US2017107212A13</originalsourceid><addsrcrecordid>eNrjZOD38w9z9VFw9vcN8A_1cwnmYWBNS8wpTuWF0twMym6uIc4euqkF-fGpxQWJyal5qSXxocFGBobmhgbmRoZGjobGxKkCAGR0HjQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>NOVEL COMPOUNDS</title><source>esp@cenet</source><creator>SCOTT William ; MÖWES Manfred ; LIENAU Philip ; GOLZ Stefan ; BASTING Daniel ; SIEGEL Franziska ; BENDER Eckhard ; THEDE Kai ; ZORN Ludwig ; PUEHLER Florian ; SCHNEIDER Dirk ; HÄGEBARTH Andrea ; MÖNNING Ursula ; GEISLER Jens ; GIESE Anja ; LIU Ningshu</creator><creatorcontrib>SCOTT William ; MÖWES Manfred ; LIENAU Philip ; GOLZ Stefan ; BASTING Daniel ; SIEGEL Franziska ; BENDER Eckhard ; THEDE Kai ; ZORN Ludwig ; PUEHLER Florian ; SCHNEIDER Dirk ; HÄGEBARTH Andrea ; MÖNNING Ursula ; GEISLER Jens ; GIESE Anja ; LIU Ningshu</creatorcontrib><description>The present invention relates to inhibitors of the Wnt signalling pathways of general formula (I) as described and defined herein, to methods of preparing said compounds, to intermediate compounds useful for preparing said compounds, to pharmaceutical compositions and combinations comprising said compounds and to the use of said compounds for manufacturing a pharmaceutical composition for the treatment or prophylaxis of a disease, in particular of a hyper-proliferative disorder, as a sole agent or in combination with other active ingredients.</description><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2017</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20170420&amp;DB=EPODOC&amp;CC=US&amp;NR=2017107212A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25563,76318</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20170420&amp;DB=EPODOC&amp;CC=US&amp;NR=2017107212A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>SCOTT William</creatorcontrib><creatorcontrib>MÖWES Manfred</creatorcontrib><creatorcontrib>LIENAU Philip</creatorcontrib><creatorcontrib>GOLZ Stefan</creatorcontrib><creatorcontrib>BASTING Daniel</creatorcontrib><creatorcontrib>SIEGEL Franziska</creatorcontrib><creatorcontrib>BENDER Eckhard</creatorcontrib><creatorcontrib>THEDE Kai</creatorcontrib><creatorcontrib>ZORN Ludwig</creatorcontrib><creatorcontrib>PUEHLER Florian</creatorcontrib><creatorcontrib>SCHNEIDER Dirk</creatorcontrib><creatorcontrib>HÄGEBARTH Andrea</creatorcontrib><creatorcontrib>MÖNNING Ursula</creatorcontrib><creatorcontrib>GEISLER Jens</creatorcontrib><creatorcontrib>GIESE Anja</creatorcontrib><creatorcontrib>LIU Ningshu</creatorcontrib><title>NOVEL COMPOUNDS</title><description>The present invention relates to inhibitors of the Wnt signalling pathways of general formula (I) as described and defined herein, to methods of preparing said compounds, to intermediate compounds useful for preparing said compounds, to pharmaceutical compositions and combinations comprising said compounds and to the use of said compounds for manufacturing a pharmaceutical composition for the treatment or prophylaxis of a disease, in particular of a hyper-proliferative disorder, as a sole agent or in combination with other active ingredients.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2017</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZOD38w9z9VFw9vcN8A_1cwnmYWBNS8wpTuWF0twMym6uIc4euqkF-fGpxQWJyal5qSXxocFGBobmhgbmRoZGjobGxKkCAGR0HjQ</recordid><startdate>20170420</startdate><enddate>20170420</enddate><creator>SCOTT William</creator><creator>MÖWES Manfred</creator><creator>LIENAU Philip</creator><creator>GOLZ Stefan</creator><creator>BASTING Daniel</creator><creator>SIEGEL Franziska</creator><creator>BENDER Eckhard</creator><creator>THEDE Kai</creator><creator>ZORN Ludwig</creator><creator>PUEHLER Florian</creator><creator>SCHNEIDER Dirk</creator><creator>HÄGEBARTH Andrea</creator><creator>MÖNNING Ursula</creator><creator>GEISLER Jens</creator><creator>GIESE Anja</creator><creator>LIU Ningshu</creator><scope>EVB</scope></search><sort><creationdate>20170420</creationdate><title>NOVEL COMPOUNDS</title><author>SCOTT William ; MÖWES Manfred ; LIENAU Philip ; GOLZ Stefan ; BASTING Daniel ; SIEGEL Franziska ; BENDER Eckhard ; THEDE Kai ; ZORN Ludwig ; PUEHLER Florian ; SCHNEIDER Dirk ; HÄGEBARTH Andrea ; MÖNNING Ursula ; GEISLER Jens ; GIESE Anja ; LIU Ningshu</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US2017107212A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2017</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>SCOTT William</creatorcontrib><creatorcontrib>MÖWES Manfred</creatorcontrib><creatorcontrib>LIENAU Philip</creatorcontrib><creatorcontrib>GOLZ Stefan</creatorcontrib><creatorcontrib>BASTING Daniel</creatorcontrib><creatorcontrib>SIEGEL Franziska</creatorcontrib><creatorcontrib>BENDER Eckhard</creatorcontrib><creatorcontrib>THEDE Kai</creatorcontrib><creatorcontrib>ZORN Ludwig</creatorcontrib><creatorcontrib>PUEHLER Florian</creatorcontrib><creatorcontrib>SCHNEIDER Dirk</creatorcontrib><creatorcontrib>HÄGEBARTH Andrea</creatorcontrib><creatorcontrib>MÖNNING Ursula</creatorcontrib><creatorcontrib>GEISLER Jens</creatorcontrib><creatorcontrib>GIESE Anja</creatorcontrib><creatorcontrib>LIU Ningshu</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>SCOTT William</au><au>MÖWES Manfred</au><au>LIENAU Philip</au><au>GOLZ Stefan</au><au>BASTING Daniel</au><au>SIEGEL Franziska</au><au>BENDER Eckhard</au><au>THEDE Kai</au><au>ZORN Ludwig</au><au>PUEHLER Florian</au><au>SCHNEIDER Dirk</au><au>HÄGEBARTH Andrea</au><au>MÖNNING Ursula</au><au>GEISLER Jens</au><au>GIESE Anja</au><au>LIU Ningshu</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>NOVEL COMPOUNDS</title><date>2017-04-20</date><risdate>2017</risdate><abstract>The present invention relates to inhibitors of the Wnt signalling pathways of general formula (I) as described and defined herein, to methods of preparing said compounds, to intermediate compounds useful for preparing said compounds, to pharmaceutical compositions and combinations comprising said compounds and to the use of said compounds for manufacturing a pharmaceutical composition for the treatment or prophylaxis of a disease, in particular of a hyper-proliferative disorder, as a sole agent or in combination with other active ingredients.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_US2017107212A1
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
title NOVEL COMPOUNDS
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-13T00%3A49%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=SCOTT%20William&rft.date=2017-04-20&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS2017107212A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true